🚨 All-In Summit Speaker Announcement: Dave Ricks
Ask about All-In Podcast
Episode Description
Tickets: https://allin.com/summit
2024 Recap: https://youtu.be/7mk4URDx-2k
-- CEO, Eli Lilly -- ~$700B market cap (world's largest pharma company) -- Leader in the GLP-1 space
Follow the besties: https://x.com/chamath https://x.com/Jason https://x.com/DavidSacks https://x.com/friedberg
Follow on X: https://x.com/theallinpod
Follow on Instagram: https://www.instagram.com/theallinpod
Follow on TikTok: https://www.tiktok.com/@theallinpod
Follow on LinkedIn: https://www.linkedin.com/company/allinpod
Intro Music Credit: https://rb.gy/tppkzl https://x.com/yung_spielburg
Intro Video Credit: https://x.com/TheZachEffect
Brief Summary
Dave, CEO of Eli Lilly, discusses GLP-1 drugs and the company's growth in the pharmaceutical market.
Key points
- Eli Liy's Market Surge. Eli Liy's market capitalization has skyrocketed by 860% since Dave became CEO.
- Revolutionary Drug Delivery. Eli Liy's experimental pill shows promise, potentially replacing injections.
Transcript
Just for the audience, Dave is the CEO of Eli Liy, which is the world's most valuable pharmaceutical company and the leader in the GLP-1 drug market. GLP-1 drugs have become increasingly popular. Eli Liy coming to save us here has had its market capitalization increase by about 860% since he became CEO. And the stock price is up a little bit more than a,000%. No need for needles. Eli Liy says it has a pill. Eli Lily's experimental pill appears to work as well as the injected drug. It's everyone's job to move the science, whether that be external science uh or internal science or we should always be pushing forward.
I'm a big fan of the pod, so I'm I'm excited to be on
